More research Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis - Scientific Reports
Single-cell and bulk transcriptomics of the liver reveals potential targets of NASH with fibrosis - Scientific Reports
https://www.practiceupdate.com/content/nafld-glycemic-control-predicts-severity-of-hepatocyte-ballooning-and-fibrosis/123967/37/9/1
Dr. Grinspoon during the KOL event was referring to therapeutic effect by Tesamorelin on glucose levels in blood and both Dr. Grinspoon and Dr. Stanley have studied the Transcriptomic effect of the drug on NASH patients. Yet again these two articles are addressing the same issues and their role of them in the condition.
There has been a shift towards understanding the condition and how to find a treatment for it which is very similar to Tesamorelin’s mechanism of action.